Rock Creek Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,000
Closed -$631K 61
2025
Q3
$631K Hold
25,000
0.07% 44
2025
Q2
$600K Sell
25,000
-55,000
-69% -$1.28M 0.07% 41
2025
Q1
$1.83M Sell
80,000
-5,633
-7% -$136K 0.22% 25
2024
Q4
$2.17M Buy
85,633
+13,933
+19% +$353K 0.23% 25
2024
Q3
$1.79M Buy
71,700
+10,043
+16% +$297K 0.2% 25
2024
Q2
$1.83M Sell
61,657
-12,862
-17% -$357K 0.24% 24
2024
Q1
$2.25M Buy
+74,519
New +$2.07M 0.28% 19

Other funds holding RTO

Rock Creek Group's RTO Position: Q4 2025 in Review

Rock Creek Group sold out of Rentokil (RTO) in Q4 2025, closing a stake of 25,000 shares — an estimated $631K sold.

Rock Creek Group first reported a position in RTO in Q1 2024 and held it in 7 quarters. The position peaked at $2.25M in Q1 2024. 254 funds tracked by Wall St. Rank hold RTO as of Q4 2025.

  • Rock Creek Group reported no remaining Rentokil position as of Q4 2025 after selling out during the quarter.
  • Rock Creek Group sold 25,000 Rentokil shares in Q4 2025, an estimated $631K.
  • Rock Creek Group first reported a position in Rentokil in Q1 2024 and held it in 7 quarters.
  • Rock Creek Group's Rentokil position peaked at $2.25M in Q1 2024.
  • 254 funds tracked by Wall St. Rank held Rentokil as of Q4 2025.

Based on Rock Creek Group's 13F filing for Q4 2025, filed 10 Feb 2026.